Locations:

Heart, Vascular and Thoracic

illustration of mitral valve transcatheter edge-to-edge repair

December 1, 2023/Heart, Vascular and Thoracic/Heart Valve Disease

The Two FDA-Approved M-TEER Systems Are Comparable at 1-Year Follow-Up, CLASP IID Data Show

And substudy reveals good outcomes with PASCAL system in patients with complex mitral valve anatomy

November 29, 2023/Heart, Vascular and Thoracic/Cardiac Surgery

Patient-Reported Outcomes Improved With Myectomy for Obstructive HCM

But improvements didn’t correlate closely with physician-assigned NYHA class, study finds

November 21, 2023/Heart, Vascular and Thoracic

Program Offers Lifelong Congenital Heart Disease Care

Surgeons discuss the vexing issue of fragmented care paradigms

illustration showing action of a GLP-1 receptor agonist

November 20, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

Semaglutide Shows Secondary Cardiovascular Prevention Benefits in Patients Without Diabetes

Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

illustration of heart and lungs with text

November 16, 2023/Heart, Vascular and Thoracic/Cardiac Surgery

Vital Statistics in Adult Cardiac Surgery, Ischemic Heart Disease and Vascular Disease (Infographic)

Check out our latest volumes and outcomes data

November 14, 2023/Heart, Vascular and Thoracic

Study Strongly Links Sleep-Related Hypoxia Metrics With Incident Atrial Fibrillation

For the first time, risk is shown after accounting for underlying contributions of pulmonary disease

November 13, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

Novel siRNA Reduces Lipoprotein(a) by More Than 90% for 48 Weeks

Undetectable levels achieved for nearly nine months in phase 1 trial

illustration of tricuspid valve regurgitation

November 10, 2023/Heart, Vascular and Thoracic/Heart Valve Disease

TRILUMINATE Health Status Analysis: T-TEER Patients Likelier to Be ‘Alive and Well’ at 1 Year

Investigators conclude that improved self-reports go beyond possible placebo effect for severe TR

November 1, 2023/Heart, Vascular and Thoracic/Heart Valve Disease

TAVR and SAVR Perform Similarly at 5 Years in Low-Risk Patients, PARTNER 3 Report Shows

Five-year data demonstrate convergence of outcomes from years 1 to 5

October 27, 2023/Genomic Medicine

Cleveland Clinic Treats First Patient With Investigational Gene Therapy for Hypertrophic Cardiomyopathy

One-time infusion of adenovirus-based therapy is designed to restore heart muscle function

BackPage 15 of 60Next